Linden Capital Partners Purchases Alcresta
Alcresta currently markets RELiZORB for enterally fed patients with pancreatic insufficiency.
Source: themiddlemarket.com
Athyrium Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Athyrium Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Athyrium Capital Today - Breaking & Trending Today
Linden Capital Partners Acquires Alcresta Therapeutics, Inc.
/PRNewswire/ -- Linden Capital Partners ("Linden"), a Chicago-based private equity firm focused exclusively on the healthcare industry, announced today the...
Source: prnewswire.com
Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Q4 2023 Earnings Call Transcript
Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Q4 2023 Earnings Call Transcript February 21, 2024 Calliditas Therapeutics AB (publ) isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Calliditas Therapeutics Q4 2023 Report. For the first part of the conference […]
Source: yahoo.com
Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Q4 2023 Earnings Call Transcript
Operator: Welcome to the Calliditas Therapeutics Q4 2023 Report. For the first part of the conference call, the participants will be in listen-only mode.
Source: insidermonkey.com
Calliditas refinances existing term loan with Euro 92 million senior secured facility with Athyrium Capital
/PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) and (Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the company has signed and fully...
Source: prnewswire.co.uk